Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials. (Q48458509)

11 February 2018

title

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials. (English)

1 reference

11 February 2018

main subject

heart failure

0 references

chronic heart failure

1 reference

8

1 reference

11 February 2018

Alberto Mantovani

9

1 reference

11 February 2018

Thor Ueland

5

object named as

Thor Ueland

1 reference

11 February 2018

2

Lars Gullestad

1 reference

11 February 2018

15

Pål Aukrust

1 reference

11 February 2018

16

Luigi Tavazzi

1 reference

11 February 2018

13

John Wikstrand

1 reference

11 February 2018

Serge Masson

3

object named as

Serge Masson

1 reference

11 February 2018

author name string

Roberto Latini

1

1 reference

11 February 2018

Ståle Haugset Nymo

4

1 reference

11 February 2018

Ivan Cuccovillo

6

1 reference

11 February 2018

Mari Vårdal

7

1 reference

11 February 2018

Donata Lucci

10

1 reference

11 February 2018

Nobuhito Masuda

11

1 reference

11 February 2018

Yukio Sudo

12

1 reference

11 February 2018

Gianni Tognoni

14

1 reference

11 February 2018

Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trials

17

1 reference

11 February 2018

publication date

27 June 2012

1 reference

11 February 2018

European Journal of Heart Failure

published in

1 reference

11 February 2018

volume

14

1 reference

11 February 2018

issue

9

1 reference

11 February 2018

page(s)

992-999

1 reference

11 February 2018

The role of monocytes and inflammation in the pathophysiology of heart failure

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

C-reactive protein in heart failure: prognostic value and the effect of valsartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Soluble CD40 ligand in acute and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

α-Defensins and outcome in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

C-reactive protein is a bystander of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

C-reactive protein: just a biomarker of inflammation or a pathophysiological player in myocardial function and morphology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

An integrated view of humoral innate immunity: pentraxins as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Regulation of leukocyte recruitment by the long pentraxin PTX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Global analysis of RNA expression profile in human vascular cells treated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Pitavastatin improves plasma pentraxin 3 and arterial stiffness in atherosclerotic patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Statins enhance formation of phagocyte extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS092

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFS092

1 reference

11 February 2018

PubMed ID

22740508

1 reference

11 February 2018